ACAD Smart Money
Acadia Pharmaceuticals Inc.
1W: -1.3%
1M: -1.8%
3M: -23.4%
YTD: -23.3%
1Y: -8.4%
3Y: -9.0%
5Y: +14.0%
$20.17
+0.43 (+2.18%)
Weekly Expected Move ±4.8%
$18
$19
$20
$21
$22
Credit Risk of going bust: lower than 86% of companies Debt: 2.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.04 (down 99.8%), Acadia Pharmaceuticals Inc. would be worth roughly what it owes.
Total debt $73.9M against a stock market value of $3.40B.
Distance to default 11.64 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $36.9M (short-term plus half of long-term), stock volatility 39.1%; Altman Z'' 3.47. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.04 (down 99.8%), Acadia Pharmaceuticals Inc. would be worth roughly what it owes.
Total debt $73.9M against a stock market value of $3.40B.
Distance to default 11.64 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $36.9M (short-term plus half of long-term), stock volatility 39.1%; Altman Z'' 3.47. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026390
Institutions Holding
+15 vs prior
123.0%
Ownership
+18.26%
48
New
136
Increased
148
Reduced
35
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-06 | Schneyer Mark C. | officer: evp, chief financial officer | S-Sale | 9,292 | $29.34 | $273K | Filing |
| 2026-08-06 | Schneyer Mark C. | officer: evp, chief financial officer | S-Sale | 5,000 | $29.00 | $145K | Filing |
| 2026-08-05 | Schneyer Mark C. | officer: evp, chief financial officer | S-Sale | 5,849 | $29.00 | $170K | Filing |
| 2026-07-30 | Thompson Elizabeth H.Z. | officer: evp, head of research & dev | S-Sale | 50 | $26.17 | $1K | Filing |
| 2026-07-30 | Thompson Elizabeth H.Z. | officer: evp, head of research & dev | S-Sale | 16,508 | $26.13 | $431K | Filing |
| 2026-06-26 | Kihara James | officer: principal accounting officer | S-Sale | 11,421 | $26.08 | $298K | Filing |
| 2026-05-29 | BAKER JULIAN | director | A-Grant/Award | 18,622 | $— | $0 | Filing |
| 2026-05-29 | BAKER FELIX | director | A-Grant/Award | 18,622 | $— | $0 | Filing |
| 2026-05-29 | Baker Brothers Life Sciences LP | director | A-Grant/Award | 18,622 | $— | $0 | Filing |
| 2026-05-29 | Baker Bros. Advisors (GP) LLC | director | A-Grant/Award | 18,622 | $— | $0 | Filing |
| 2026-05-29 | 667, L.P. | director | A-Grant/Award | 18,622 | $— | $0 | Filing |
| 2026-05-29 | BAKER BROS. ADVISORS LP | director | A-Grant/Award | 18,622 | $— | $0 | Filing |
| 2026-05-26 | Kihara James | officer: principal accounting officer | S-Sale | 5,401 | $21.18 | $114K | Filing |
| 2026-05-04 | Schneyer Mark C. | officer: evp, chief financial officer | S-Sale | 3,506 | $21.79 | $76K | Filing |
| 2026-05-04 | Kihara James | officer: principal accounting officer | S-Sale | 1,332 | $21.79 | $29K | Filing |
| 2026-04-07 | Kihara James | officer: principal accounting officer | S-Sale | 1,030 | $22.20 | $23K | Filing |
| 2026-04-07 | Schneyer Mark C. | officer: evp, chief financial officer | S-Sale | 2,709 | $22.20 | $60K | Filing |
| 2026-03-26 | Schneyer Mark C. | officer: evp, chief financial officer | S-Sale | 37 | $21.72 | $804 | Filing |
| 2026-03-26 | Schneyer Mark C. | officer: evp, chief financial officer | S-Sale | 3,171 | $21.65 | $69K | Filing |
| 2026-03-26 | Kihara James | officer: principal accounting officer | S-Sale | 12 | $21.73 | $261 | Filing |
| 2026-03-26 | Kihara James | officer: principal accounting officer | S-Sale | 1,097 | $21.65 | $24K | Filing |
| 2026-03-25 | Rhodes Jennifer J | officer: evp, chief legal officer, sec | S-Sale | 3,844 | $21.47 | $83K | Filing |
| 2026-03-25 | Kihara James | officer: principal accounting officer | S-Sale | 833 | $21.47 | $18K | Filing |
| 2026-03-25 | Thompson Elizabeth H.Z. | officer: evp, head of research & dev | S-Sale | 3,435 | $21.47 | $74K | Filing |
| 2026-03-25 | Owen Adams Catherine | officer: chief executive officer | S-Sale | 11,641 | $21.47 | $250K | Filing |
🏛️ Congressional Trades
3 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| 2022-06-16 | Chris Jacobs | House | Sell | $1,001 - $15,000 | Filing |
| 2020-09-08 | Chris Jacobs | House | Sell | $1,001 - $15,000 | Filing |
| 2019-02-19 | Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Filing |
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 42,912,904 | $1.1B | +16,214 | 2026-06-30 | Filing |
| BlackRock, Inc. | 22,515,173 | $570M | +964,252 | 2026-06-30 | Filing |
| STATE STREET CORP | 9,076,212 | $230M | +743,441 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8,838,450 | $224M | +166,805 | 2026-06-30 | Filing |
| RTW INVESTMENTS, LP | 7,144,524 | $181M | — | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,763,750 | $146M | +102,350 | 2026-06-30 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 3,694,988 | $93M | +539,828 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 3,358,129 | $85M | -106,560 | 2026-06-30 | Filing |
| Palo Alto Investors LP | 2,864,096 | $72M | -8,599 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 2,580,115 | $65M | +1,022,311 | 2026-06-30 | Filing |
| Qube Research & Technologies Ltd | 2,446,610 | $62M | +1,496,311 | 2026-06-30 | Filing |
| Point72 Asset Management, L.P. | 2,433,168 | $62M | -144,748 | 2026-06-30 | Filing |
| CITADEL ADVISORS LLC | 2,182,177 | $55M | +1,559,417 | 2026-06-30 | Filing |
| Pictet Asset Management Holding SA | 1,983,198 | $50M | -42,846 | 2026-06-30 | Filing |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,969,445 | $50M | +399,954 | 2026-06-30 | Filing |
| MARSHALL WACE, LLP | 1,764,838 | $45M | +1,688,651 | 2026-06-30 | Filing |
| D. E. Shaw & Co., Inc. | 1,697,937 | $43M | +968,101 | 2026-06-30 | Filing |
| BRAIDWELL LP | 1,646,399 | $42M | -824,800 | 2026-06-30 | Filing |
| NORGES BANK | 1,623,308 | $41M | +1,623,308 | 2026-06-30 | Filing |
| Frazier Life Sciences Management, L.P. | 1,438,198 | $36M | — | 2026-06-30 | Filing |